White label – Pompe disease - ClinicalTrials.eu

Study on Pembrolizumab with Chemotherapy for Early-Stage Triple-Negative Breast Cancer in Patients with High TILs

Recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
Study of Cytarabine, Daunorubicin, and Clofarabine for Children with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Recruiting

1 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study on the Safety and Effectiveness of Abatacept and Daratumumab for Patients with Rheumatoid Arthritis

Recruiting

1 1 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Abatacept
- Daratumumab
Study on Iron and Mannitol for Anemia Recovery in Patients After Major Surgery with Blood Loss

Recruiting

3 1 1 1
Investigated Diseases:
- Anaemia
Investigated Drugs:
- Mannitol
Study on Adding Elacestrant to Olaparib for Patients with HR-Positive, HER2-Negative Advanced Breast Cancer with gBRCA1/2 Mutations

Recruiting

2 1 1 1
Investigated Drugs:
- Elacestrant Dihydrochloride
- Olaparib
Long-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

Recruiting

3 1 1 1
Investigated Drugs:
Long-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001

Recruiting

3 1 1
Investigated Diseases:
- Duchenne muscular dystrophy
Investigated Drugs:
- Delandistrogene Moxeparvovec
Study on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging

Recruiting

2 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
- Zirconium (89Zr) Crefmirlimab Berdoxam
Study on the Effectiveness of Ozanimod for Children with Moderate to Severe Ulcerative Colitis Not Responding to Usual Treatment

Recruiting

4 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Ozanimod
Study on Durvalumab, Etoposide, and Platinum Drug Combination for First-Line Treatment of Advanced Large-Cell Neuroendocrine Lung Cancer Patients

Recruiting

2 1 1 1
Investigated Diseases:
- Neuroendocrine tumour of the lung
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies